CATHRINE YEAGER: Open Payments
NPI 1184267791 · CROFTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 24 payments from 9 companies in 2025. Trend: 2023 $1,533 · 2024 $1,867 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $152 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Amgen Inc. | 2 | $42 |
| Optinose US, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $23 |
| Grifols USA, LLC | 1 | $23 |
Products named: TEZSPIRE, DUPIXENT, NEFFY, NUCALA, Xhance, CIBINQO, Prolastin-C Liquid, FASENRA.
Industry payments across MD — which companies pay providers there.
